Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes

Basic Research in Cardiology

Volumn 96, Issue 1, 2001, Pages 34-41

  Patel, K N ^a   Yan, L ^a   Gandhi, A ^a   Scholz, P M ^a   Weiss, H R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cardiac myocytes; Cyclic AMP; Cyclic AMP phosphodiesterase; Cyclic GMP; Myocyte shortening; Renal hypertension

Indexed keywords

CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; FORSKOLIN;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HEART HYPERTROPHY; HEART MUSCLE CELL; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; RABBIT; RENOVASCULAR HYPERTENSION;

ANIMALS; CARDIOMEGALY; CELL SEPARATION; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HYPERTENSION, RENOVASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIUM; RABBITS; REFERENCE VALUES;

EID: 0035154157     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950170075     Document Type: Article

References (32)

1. Kinetics of cyclic adenosine monophosphate changes in rat heart following epinephrine administration
2. Reduction of cardiac hypertrophy in renal hypertensive rabbits with pindolol
3. 2 supply/consumption in hypertension-induced myocardial hypertrophy
4. 2+ channels by cyclic AMP and cyclic GMP-dependent protein kinase in Pleurodeles oocytes
5. Inhibition of smooth muscle growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
6. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation
7. The cAMP response element binding protein is expressed and phosphorylated in cardiac myocytes
8. Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extent under conditions of increased metabolism
9. Regulation of the calcium slow channel by cyclic GMP dependent protein kinase in chick heart cells
10. Regulation of myocardial calcium channels by cyclic AMP metabolism
11. Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes
12. Renovascular hypertension: A paradigm for all hypertension
13. Signal transduction by cGMP in heart
14. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes
15. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
16. The nitric oxide-cGMP signal transduction system for intracellular and intracellular communication
17. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts
18. Increase in myocardial cell cGMP concentration in pressure-induced myocardial hypertrophy
19. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy
20. 2+ in intact cardiac myocytes
21. Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells
22. 2 consumption is altered in renal hypertension
23. Intracellular signaling through protein kinases in the heart
24. 2+ current in rat ventricular myocytes
25. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase
26. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system
27. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle
28. Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility
29. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases
30. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts
31. Relationship between adenylate cyclase activity and regional myocardial energetics in experimental left ventricular hypertrophy
32. 2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels